When I received my multiple sclerosis diagnosis 15 years ago, I knew my life would be forever changed. From skiing to tennis, I love being outdoors, and the diagnosis hit me hard mentally and emotionally, knowing I had a disease that would slowly disrupt my ability to move freely. I maintained my active lifestyle for some time, but in 2012, I started using a wheelchair, and today, my condition requires full-time professional assistance. But I still move around as much as I can—MS may have inhibited my physical ability, but not my fighting spirit!
Even in the last decade, the landscape for MS treatment has changed dramatically, and I know that’s the result of the American innovation ecosystem at work. I get worried when I hear about government proposals that could disrupt this system, or, worse, give control to politicians over where we can invest in new treatments. I agree our health care system needs reforms to help patients afford their medicines, but we don’t need to give control over to the government.
Sign up to stay informed and learn how to protect innovation when it matters most.
©2024 Pharmaceutical Research and Manufacturers of America, 670 Maine Avenue, SW, Suite 1000, Washington, DC 20024
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.
